V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330007487 | 330004305 | null | null | Neo-adjuvant (N) | 2017-12-08 | 2017-12-09 | Cetuximab 7 day (>Cycle 2) | N | N | 330011097 | CETUXIMAB |
| 330007488 | 330004306 | 1.5 | 57.9 | Curative (C) | 2015-11-24 | 2016-04-19 | Cetuximab 7 day (Cycle 1) | 2 | N | 330011174 | CETUXIMAB |
| 330007489 | 330004306 | 1.7 | 52 | Curative (C) | 2017-07-17 | 2017-10-02 | OST Euramos 1 Closed Trial - M | N | N | 330011174 | METHOTREXATE HIGH DOSE |
| 330007490 | 330004309 | 1.76 | 61 | Curative (C) | 2013-09-02 | 2013-11-15 | CISPLATIN + FLUOROURACIL | N | Y | 330011205 | CISPLATIN + FLUOROURACIL |
| 330007491 | 330008357 | null | 58.3 | Curative (C) | null | 2014-05-26 | ETOPOSIDE + IFOSFAMIDE | null | null | 330011205 | ETOPOSIDE + IFOSFAMIDE |
| 330007492 | 330008357 | 1.82 | 87.8 | Neo-adjuvant (N) | 2015-10-03 | 2015-10-04 | CISPLATIN + FLUOROURACIL | N | N | 330011205 | CISPLATIN + FLUOROURACIL |
| 330007493 | 330004311 | 1.83 | 67 | Palliative (P) | 2017-10-23 | 2017-10-23 | CETUXIMAB | N | N | 330011224 | CETUXIMAB |
| 330007494 | 330008358 | 1.84 | 71.8 | Curative (C) | 2017-11-27 | 2017-11-27 | CARBOPLATIN | N | N | 330011236 | CARBOPLATIN |
| 330007495 | 330008358 | 1.68 | 69.3 | Curative (C) | 2018-03-18 | 2018-06-14 | Carboplatin AUC 2 - 5 | N | Y | 330011236 | CARBOPLATIN |
| 330007496 | 330004313 | 1.6 | 77.9 | null | null | 2017-04-28 | Cetuximab 7 day (>Cycle 2) | N | N | 330011267 | CETUXIMAB |
| 330007497 | 330004317 | 1.7 | 53.6 | Curative (C) | 2015-02-12 | 2015-05-16 | Cetuximab 7 day (>Cycle 2) | 2 | N | 330011269 | CETUXIMAB |
| 330007498 | 330004317 | null | 61.3 | null | 2014-04-20 | 2015-01-05 | OST Euramos 1 Closed Trial - M | N | N | 330011269 | METHOTREXATE HIGH DOSE |
| 330007499 | 330004317 | 1.73 | 62.1 | Curative (C) | 2018-05-29 | 2018-06-04 | Carboplatin AUC 6 - 10 | 02 | N | 330011269 | CARBOPLATIN |
| 330007500 | 330008360 | 1.62 | 78 | Palliative (P) | 2013-07-19 | 2013-08-06 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 330011276 | CISPLATIN + FLUOROURACIL |
| 330007501 | 330008360 | null | 87.6 | Adjuvant (A) | 2017-08-22 | 2017-09-09 | MAP | null | null | 330011276 | MAP |
| 330007502 | 330004321 | 0 | 57.7 | Curative (C) | 2017-03-04 | 2017-03-04 | DOCETAXEL + GEMCITABINE | N | null | 330011299 | DOCETAXEL + GEMCITABINE |
| 330007503 | 330004322 | 1.71 | 24.6 | Adjuvant (A) | 2017-10-03 | 2017-11-21 | Cisplatin +Fluorouracil (3 wk) | N | N | 330011311 | CISPLATIN + FLUOROURACIL |
| 330007504 | 330004325 | 1.81 | 55.5 | Palliative (P) | 2015-07-30 | 2015-07-30 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 330011340 | CISPLATIN + FLUOROURACIL |
| 330007505 | 330004330 | 1.71 | null | null | 2013-08-17 | 2013-09-10 | DOCETAXEL + GEMCITABINE | Y | Y | 330011341 | DOCETAXEL + GEMCITABINE |
| 330007506 | 330008365 | 1.67 | 70 | Curative (C) | 2013-11-06 | 2014-03-02 | Cetuximab 7 day (>Cycle 2) | N | null | 330011341 | CETUXIMAB |
| 330007507 | 330004332 | 1.8 | 66 | Palliative (P) | 2016-06-10 | 2016-06-13 | CISPLATIN + FLUOROURACIL | 02 | N | 330011367 | CISPLATIN + FLUOROURACIL |
| 330007508 | 330004332 | null | null | Curative (C) | 2017-10-21 | 2017-10-23 | Etoposide + Ifosfamide (5 days) | 02 | N | 330011367 | ETOPOSIDE + IFOSFAMIDE |
| 330007509 | 330004334 | 1.73 | 79.9 | Palliative (P) | 2015-07-30 | 2015-08-27 | CISPLATIN + FLUOROURACIL | N | N | 330011387 | CISPLATIN + FLUOROURACIL |
| 330007510 | 330012420 | 1.71 | null | Neo-adjuvant (N) | 2017-10-20 | 2017-10-20 | Carboplatin AUC 2 - 5 | 2 | N | 330011387 | CARBOPLATIN |
| 330007511 | 330012420 | null | 57.2 | Palliative (P) | null | 2018-02-27 | CISPLATIN + FLUOROURACIL | N | N | 330011387 | CISPLATIN + FLUOROURACIL |
| 330007512 | 330012420 | null | 82.4 | null | null | 2015-09-15 | Docetaxel + Gemcitabine (prior RT) | null | null | 330011387 | DOCETAXEL + GEMCITABINE |
| 330007513 | 330012420 | 1.75 | 0 | Curative (C) | 2015-04-29 | 2015-04-29 | Etoposide + Ifosfamide (3 days) | 02 | N | 330011387 | ETOPOSIDE + IFOSFAMIDE |
| 330007514 | 330012420 | 1.81 | null | Palliative (P) | 2014-03-18 | 2014-03-19 | Rituximab | null | null | 330011387 | RITUXIMAB |
| 330007515 | 330004336 | 1.81 | 70.9 | Adjuvant (A) | null | 2017-06-04 | MAP | Y | N | 330011441 | MAP |
| 330007516 | 330004337 | 1.84 | null | Disease modification (D) | 2016-10-20 | 2016-10-26 | Methotrexate High Dose (3g/m2) | null | null | 330011449 | METHOTREXATE HIGH DOSE |
| 330007517 | 330008368 | 1.59 | 63 | Curative (C) | 2015-08-04 | 2016-06-16 | OST Euramos 1 Closed Trial - M | 2 | N | 330011449 | METHOTREXATE HIGH DOSE |
| 330007518 | 330012803 | null | 57 | null | 2013-11-07 | 2013-11-13 | CETUXIMAB | N | null | 330011453 | CETUXIMAB |
| 330007519 | 330004338 | 1.59 | 82.7 | Curative (C) | 2017-08-20 | 2017-08-20 | PAM x 2 post-surgery (cycles 3&4) | 2 | N | 330011463 | MAP |
| 330007520 | 330004339 | 1.7 | 62.3 | Adjuvant (A) | 2016-02-28 | 2016-08-13 | CARBOPLATIN | N | N | 330011479 | CARBOPLATIN |
| 330007521 | 330004344 | 1.62 | 87.7 | Palliative (P) | 2015-02-04 | 2015-02-17 | ETOPOSIDE + IFOSFAMIDE | N | N | 330011479 | ETOPOSIDE + IFOSFAMIDE |
| 330007522 | 330004345 | 1.82 | null | Neo-adjuvant (N) | 2013-10-14 | 2014-03-30 | CISPLATIN + FLUOROURACIL | N | N | 330011480 | CISPLATIN + FLUOROURACIL |
| 330007523 | 330004346 | null | 58 | Curative (C) | 2014-05-02 | 2014-05-03 | PAM x 2 pre-surgery (cycles 1&2) | null | N | 330011497 | MAP |
| 330007524 | 330004349 | 1.62 | 60.3 | Curative (C) | 2014-01-28 | 2014-02-11 | Docetaxel+Gemcitabine (no prior RT) | N | N | 330011499 | DOCETAXEL + GEMCITABINE |
| 330007525 | 330004351 | null | null | Curative (C) | 2016-09-07 | 2016-09-26 | CISPLATIN + FLUOROURACIL | null | null | 330011502 | CISPLATIN + FLUOROURACIL |
| 330007526 | 330004351 | 1.65 | null | Curative (C) | 2013-09-18 | 2013-09-18 | CISPLATIN + FLUOROURACIL | Y | N | 330011502 | CISPLATIN + FLUOROURACIL |
| 330007527 | 330004351 | 1.9 | 115.9 | Palliative (P) | 2017-07-25 | 2017-08-18 | CISPLATIN + FLUOROURACIL | N | N | 330011502 | CISPLATIN + FLUOROURACIL |
| 330007528 | 330004354 | null | 48.6 | Curative (C) | 2014-10-04 | 2014-11-01 | Cetuximab 7 day (Cycle 1) | 02 | null | 330011517 | CETUXIMAB |
| 330007529 | 330010546 | null | 75 | Palliative (P) | 2015-01-09 | 2015-01-25 | Rituximab | N | N | 330011524 | RITUXIMAB |
| 330007530 | 330004357 | 1.71 | 51.2 | Not known (9) | 2014-02-26 | 2014-03-02 | Carboplatin AUC 6 - 10 | N | N | 330011529 | CARBOPLATIN |
| 330007531 | 330004360 | 1.8 | 68.9 | Curative (C) | 2017-05-02 | 2017-05-12 | PAM x 2 post-surgery (cycles 3&4) | N | N | 330011549 | MAP |
| 330007532 | 330004360 | 1.6 | 59.6 | Palliative (P) | null | 2014-12-08 | CETUXIMAB | 2 | N | 330011549 | CETUXIMAB |
| 330007533 | 330004361 | 1.8 | null | Palliative (P) | 2014-09-20 | 2014-09-21 | PAM x 2 post-surgery (cycles 3&4) | null | N | 330011562 | MAP |
| 330007534 | 330004362 | 1.7 | 55.4 | Curative (C) | 2017-08-21 | 2017-08-25 | Rituximab (INTRAVENOUS Maintenance) | Y | N | 330011594 | RITUXIMAB |
| 330007535 | 330004363 | 1.9 | 54.2 | Curative (C) | 2017-08-26 | 2017-09-02 | CETUXIMAB | N | N | 330011598 | CETUXIMAB |
| 330007536 | 330004368 | null | 78.2 | Not known (9) | 2017-07-30 | 2017-07-30 | CISPLATIN + FLUOROURACIL | Y | Y | 330011603 | CISPLATIN + FLUOROURACIL |